This site is intended for health professionals only

At the heart of general practice since 1960

Read the latest issue online

CAMHS won't see you now

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Your comments will be sent to our moderator for review.

Report comment to moderator

Required fields.


Government medicine regulator launches major opioids review to cut prescribing


The underlying problem here is that optimal use (or non-use!) of opiates (for chronic non-fatal pathologies) involves the doc making a subjective judgement about a patient's pain and personality. These decisions can rarely be completely right or completely wrong. This balancing process is made more difficult by a "points mean prizes" benefits system that is seen as the only viable income option by some patients. Many GPs have been surprised over the years by the decisions made by many pain clinic consultants. I agree with most of the other commentators here. There are two main points being made: 1) Starting a patient on potent opiates - or gabapentinoids - is infinitely easier than stopping them. (A point repeatedly denied by some proponents of some pain management strategies.) 2) It seems rather unfair for one group of docs to undertaking the easy bit (starting!) and for another group of docs to have to cope with the task of trying to stop the stuff.

Posted date

16 Feb 2019

Posted time